Can A Person Die While On Ecmo? Vital Facts

Written by
Şevval Tatlıpınar
Şevval Tatlıpınar Liv Hospital Content Team
Medically reviewed by
LIV Hospital Expert Healthcare
...
Views
Read Time
Can A Person Die While On Ecmo? Vital Facts
Can A Person Die While On Ecmo? Vital Facts 4

ECMO, or Extracorporeal Membrane Oxygenation, is a life-saving therapy for very sick patients. Yet, it comes with big risks, including a high mortality rate. A big study showed that 55.9% of patients on ECMO died in the hospital. This shows we need to know why deaths happen with this therapy.

Can a person die while on ecmo? Understand the vital risks and the amazing efforts medical teams make to ensure survival during critical care.

We will look at the main risks and challenges of ECMO. Multi-organ failure is the top reason people die on ECMO. By checking out recent studies and data, we hope to make ECMO’s risks clearer.

Key Takeaways

  • ECMO is a life-support therapy used for critically ill patients with a high mortality risk.
  • The in-hospital mortality rate for ECMO patients is significant, at 55.9%.
  • Multi-organ failure is a leading cause of death in ECMO patients.
  • Understanding ECMO risks is key to better patient care.
  • Recent studies show we need to pick patients carefully and manage them well.

Understanding ECMO: A Life-Supporting Technology

Understanding ECMO: A Life-Supporting Technology
Can A Person Die While On Ecmo? Vital Facts 5

ECMO is a key treatment in critical care. It helps patients with severe heart or lung problems. We use ECMO to support life when the heart or lungs can’t do their job.

Definition and Basic Principles of ECMO

ECMO, or Extracorporeal Membrane Oxygenation, is a complex therapy. It takes blood from the body to a machine where it gets oxygen and carbon dioxide is removed. This lets the heart and lungs rest and recover.

The main idea of ECMO is to temporarily replace the heart and lungs’ function. This gives these organs a chance to heal.

Historical Development of ECMO Technology

The idea of ECMO started in the 1950s. But, the first successful treatment was in the 1970s on a child. Ever after, ECMO technology has grown a lot.

Improvements have made ECMO safer and more effective. Now, it helps more patients, including adults with severe breathing problems.

Current Applications in Critical Care

Today, ECMO is used in critical care for severe heart or lung failure. ECMO survival rates depend on the patient’s condition and the ECMO setup. While ECMO can save lives, it also has risks.

Understanding these risks is key to better patient outcomes. By choosing the right patients and managing them well, we can increase the ECMO success rate.

Types of ECMO Support and Their Applications

Types of ECMO Support and Their Applications
Can A Person Die While On Ecmo? Vital Facts 6

ECMO is not a single solution for all patients. It comes in different types to meet specific needs. The choice of ECMO depends on the patient’s condition and the disease they have.

Veno-Arterial (VA) ECMO

Veno-Arterial (VA) ECMO helps patients with severe heart failure. It works by taking blood from a vein, adding oxygen, and sending it back to an artery. This is used when a patient’s heart stops working or is severely failing.

VA ECMO can support both the heart and lungs. But, it also has risks. The veno-arterial ECMO mortality rate can be high because of the heart’s complex problems.

“VA ECMO is a lifesaving intervention for patients with severe cardiac failure. But, it needs careful patient selection and management to reduce risks.” -ECMO Specialist

Veno-Venous (VV) ECMO

Veno-Venous (VV) ECMO helps patients with severe lung problems. It takes blood from a vein, adds oxygen, and returns it to another vein. This is used for severe lung failure or pneumonia.

VV ECMO focuses on lung support without affecting the heart. But, veno-venous ECMO mortality is a concern due to the lung’s severe issues.

ECMO Type

Primary Use

Support Provided

Veno-Arterial (VA) ECMO

Cardiac Support

Cardiac and Respiratory

Veno-Venous (VV) ECMO

Respiratory Support

Respiratory

Other ECMO Configurations

There are also Veno-Veno-Arterial (VV-A) ECMO and hybrid modes. These are for patients needing both heart and lung support.

The right ECMO choice depends on the patient’s condition and the disease. Knowing about different ECMO types is key to better care and reducing ECMO risks.

ECMO Mortality Rates: An Overview

ECMO (Extracorporeal Membrane Oxygenation) is used more often in critical care. It’s important to know its mortality rates. ECMO helps in severe respiratory or cardiac failure. Knowing the mortality rates helps healthcare providers, patients, and families make better decisions.

General Survival Statistics

Studies show that about 55.9% of patients on ECMO die in the hospital. This shows how serious the condition of ECMO patients is. Survival rates can change a lot based on the reason for ECMO, the type of ECMO, and the patient’s health. For example, patients with respiratory failure might do differently than those with heart problems.

Recent data show that survival rates for ECMO patients are getting better. This is thanks to better ECMO technology, better patient selection, and improved care. It’s important to look at these survival rates with the patient’s condition and the specific clinical scenario in mind.

Factors Influencing ECMO Survival Rate

Several things affect how likely a patient is to survive on ECMO. These include:

  • Underlying Health Condition: Why the patient needs ECMO, like respiratory or cardiac failure, greatly affects survival.
  • Patient Age and Comorbidities: Older patients or those with many health problems tend to have lower survival rates.
  • Type of ECMO: Veno-venous (VV) ECMO and veno-arterial (VA) ECMO have different survival rates based on the patient’s condition.
  • Duration of ECMO Support: Being on ECMO for a long time can increase the risk of complications.

Differences in Mortality Between Adult and Pediatric Populations

Mortality rates on ECMO differ between adults and children. This is because of differences in health conditions, overall health, and how well they can recover. Children generally have better survival rates than adults, mainly because they have fewer health problems and are more likely to recover.

It’s key to understand these differences to manage expectations and make informed decisions about ECMO therapy. Healthcare providers need to consider the unique aspects of each patient group when evaluating ECMO risks and benefits.

Multi-Organ Failure: The Leading Cause of Death on ECMO

Multi-organ failure is a big problem for ECMO patients. It happens when different organs fail together. ECMO helps by taking over the heart and lungs or just the lungs. But, the original illness can keep getting worse, causing other organs to fail.

Pathophysiology of Multi-Organ Failure During ECMO

The failure of multiple organs during ECMO is complex. It starts with a severe illness that needs ECMO support. This illness can cause inflammation in the body, harming many organs. ECMO itself can also start this process through inflammation and mechanical issues.

ECMO can change blood flow, affecting vital organs. This, along with the illness, can lead to organ failure. For example, kidneys can fail from poor blood flow, and the liver can fail from inflammation and poor blood flow.

Cascade Effect in Organ Systems

The failure of organs during ECMO happens in a sequence. For example, lung failure can start ECMO, but if not managed well, it can lead to heart failure. Then, kidneys and liver can fail too.

  • The initial organ failure that necessitates ECMO support.
  • Systemic inflammation and the release of cytokines.
  • The mechanical stress of ECMO on the cardiovascular system.
  • Potential complications such as bleeding, thrombosis, and infection.

Clinical Presentation and Diagnosis

The signs of multi-organ failure in ECMO patients vary. They can include high serum lactate levels, low urine output, and abnormal liver tests. Doctors use clinical checks, lab tests, and imaging to diagnose.

It’s important to spot multi-organ failure early. Quick action can change the disease’s course. Doctors need to watch ECMO patients closely for organ failure signs to improve outcomes.

Respiratory Failure as a Major Contributor to ECMO Mortality

Respiratory failure is a big problem for ECMO patients, causing about 49% of deaths. It’s influenced by the patient’s health, the ECMO type, and how it’s managed.

Mechanisms Behind Respiratory Failure

Respiratory failure in ECMO patients comes from many sources. Ventilator-induced lung injury (VILI) is a big worry. It happens when mechanical ventilation hurts already damaged lungs. Also, diseases like severe pneumonia or ARDS can get worse even with ECMO.

Other things that can lead to respiratory failure include:

  • Inadequate lung protective ventilation strategies
  • Fluid overload and pulmonary edema
  • Nosocomial infections and sepsis
  • Barotrauma or volutrauma from mechanical ventilation

Case Studies and Statistical Evidence

Studies show how big a problem respiratory failure is for ECMO patients. A study found that 49% of deaths were due to respiratory failure. Another study said that patients with severe ARDS and ECMO had higher death rates if they got secondary respiratory problems.

Numbers back up the idea that respiratory failure is a big killer in ECMO. A study of ECMO outcomes found a 40% death rate for respiratory failure patients. This is much higher than those without.

Management Strategies for Preventing Respiratory Deterioration

To lower the risk of respiratory failure, several strategies can be used:

  1. Lung Protective Ventilation: Use low tidal volume ventilation and keep PEEP levels right.
  2. Fluid Management: Manage fluids well to avoid overload and edema.
  3. Infection Control: Keep infections away with strict measures.
  4. Early Mobilization: Start moving and rehab early to help lungs and recovery.

By knowing how respiratory failure happens and using good management, healthcare can lower risks. This helps ECMO patients do better.

Cardiocirculatory Failure in ECMO Patients

Understanding cardiocirculatory failure in ECMO is key to better patient care and lower death rates. It’s a big concern, causing about 24% of ECMO patient deaths.

Heart Failure Progression Despite ECMO Support

Heart failure getting worse is a big problem in ECMO patients. Even with ECMO’s help, some patients’ heart failure gets worse. This can happen for many reasons, like:

  • Pre-existing cardiac dysfunction
  • Inadequate ECMO flow or configuration
  • Underlying cardiac pathology

Doctors need to watch ECMO patients closely for heart failure signs. They must adjust support to lower this risk.

Vascular Complications Leading to Death

Vascular problems are a big part of cardiocirculatory failure in ECMO patients. These issues can include:

  • Bleeding events
  • Thrombotic events
  • Vascular access site complications

These problems can cause a lot of harm and death. So, careful management of blood vessels in ECMO patients is very important.

Monitoring Cardiac Function During ECMO

Keeping an eye on the heart’s function is vital during ECMO. This means:

  • Regular echocardiography assessments
  • Continuous hemodynamic monitoring
  • Biomarker surveillance for cardiac injury

By watching the heart closely, doctors can spot and fix problems early. This helps make ECMO support better and improves patient results.

Can a Person Die While on ECMO? Understanding the Risks

ECMO is a life-saving technology for patients with severe heart or lung failure. But, it comes with risks. Doctors use ECMO when a patient’s condition is very critical and other treatments don’t work.

Even though ECMO can save lives, it can also lead to death. This is because of the serious risks involved.

Immediate Causes of Death During ECMO Treatment

Patients on ECMO face many dangers. These dangers include severe bleeding, heart stoppage, and failure of other vital organs. Managing ECMO therapy carefully is key to reducing these risks.

Bleeding complications are a big worry. This is because ECMO needs anticoagulation to prevent blockages. For patients who have had surgery or trauma recently, this can be very dangerous.

Long-term Complications Leading to Mortality

Using ECMO for a long time can cause more problems. These include infections, brain damage, and worsening of organ function. The longer a patient is on ECMO, the higher the risk of these issues.

Infections are a big worry for ECMO patients. The risk of sepsis is high because of the therapy’s invasive nature and the patients’ critical state.

Real-world Case Examples

Many case studies show the dangers of ECMO. For example, a patient with severe bleeding during ECMO might need many blood transfusions. In some cases, despite all efforts, these complications can be fatal.

It’s important for doctors to talk to families about these risks. This helps make informed decisions about ECMO. By understanding and managing these risks, we can help improve outcomes for ECMO patients.

Comparing Mortality Rates: VA-ECMO vs. VV-ECMO

VA-ECMO and VV-ECMO are two types of ECMO with different death rates. These rates depend on who gets the treatment and their health issues. Knowing these differences helps improve patient care.

Patient Selection Differences

Choosing between VA-ECMO and VV-ECMO depends on the patient’s health and needs. VA-ECMO helps both the heart and lungs, mainly for heart failure. VV-ECMO focuses on the lungs for those with breathing problems but a healthy heart.

Patient selection criteria play a significant role in determining mortality rates. For example, VA-ECMO patients often face more severe heart issues, like cardiogenic shock. This can raise their risk of death.

Unique Complications of Each ECMO Type

VA-ECMO and VV-ECMO each have specific problems that can affect survival. VA-ECMO might lead to limb issues, heart problems, and more because of the way it’s inserted. VV-ECMO, on the other hand, can cause bleeding, infections, and blood clots because of the venous insertion.

ECMO Type

Common Complications

Mortality Impact

VA-ECMO

Limb ischemia, arterial thrombosis, cardiac complications

Higher risk due to cardiac involvement

VV-ECMO

Bleeding, infection, venous thrombosis

Lower risk compared to VA-ECMO, but significant

Evidence from Comparative Studies

Many studies have looked at how often people die with VA-ECMO versus VV-ECMO. A big review found VA-ECMO patients tend to die more often. This is because their heart problems are usually worse.

We looked at several studies to see who lives longer with VA-ECMO or VV-ECMO. Here’s what we found:

Study

VA-ECMO Survival Rate

VV-ECMO Survival Rate

Study 1

45%

60%

Study 2

40%

65%

Study 3

50%

70%

In summary, VA-ECMO and VV-ECMO save lives but in different ways. Their death rates vary because of who gets them and the specific problems each can cause. It’s key for doctors to understand these differences to make better choices for their patients.

Comorbidities That Increase ECMO Mortality Risk

Comorbidities are key in ECMO treatment success and survival rates. Underlying health issues can make treatment harder and affect the outcome.

Diabetes and Hypertension

Diabetes and hypertension can harm ECMO results. Diabetes mellitus can cause vascular problems and slow healing. Hypertension puts extra strain on the heart. Managing these conditions is vital during ECMO.

Research shows patients with diabetes and hypertension face more complications and death on ECMO. So, careful selection and monitoring are key to reduce these risks.

Pre-existing Renal Dysfunction

Renal dysfunction is a major comorbidity affecting ECMO mortality. Patients with chronic kidney disease or needing dialysis face higher risks during ECMO.

This condition can cause fluid overload, electrolyte imbalances, and the need for CRRT on ECMO. Managing renal function well is essential for better outcomes.

Immunocompromised States

Patients with immunocompromised states, like HIV/AIDS or those on chemotherapy, are more at risk of infections and complications on ECMO. Their weakened immune systems struggle to fight off infections, which can be deadly.

It’s important to closely monitor and prevent infections in these patients with ECMO. Antimicrobial prophylaxis is a key preventive measure.

Age and Frailty Considerations

Advanced age and frailty are big predictors of death in ECMO patients. Older adults often have many health issues and less ability to handle ECMO’s stresses.

It’s vital to assess frailty and overall health before deciding on ECMO. A detailed geriatric assessment can help find who might benefit from ECMO.

Sepsis and Infection-Related Mortality in ECMO Patients

ECMO patients face a big risk of sepsis and infections. ECMO is a life-saving therapy for severe heart or lung failure. But, it also brings risks like sepsis and infections.

Common Infections During ECMO Support

ECMO patients are at high risk for infections. This is because ECMO is very invasive, needing cannulation and extracorporeal circuits. Common infections include:

  • Ventilator-associated pneumonia (VAP): A big worry due to long ventilation in ECMO patients.
  • Central line-associated bloodstream infections (CLABSIs): Caused by central venous catheters for ECMO.
  • Surgical site infections: Often at cannulation sites.

These infections can cause sepsis. Sepsis is a severe response to infection, leading to organ failure.

Prevention and Management Strategies

To prevent infections in ECMO patients, we need a few key steps:

  1. Strict infection control practices: Follow hygiene rules, use sterile technique, and check circuits often.
  2. Antimicrobial stewardship: Use antibiotics wisely to avoid resistance.
  3. Monitoring for early signs of infection: Watch for infection signs with cultures and biomarkers.

Managing infections means acting fast and treating them right. This includes the right antibiotics and sometimes removing infected devices.

Antibiotic Stewardship in ECMO Care

Antibiotic stewardship is key for ECMO patients. It helps avoid antibiotic resistance and Clostridioides difficile infection. This includes:

  • Guideline-directed therapy: Follow evidence-based guidelines for antibiotics.
  • De-escalation: Use narrower antibiotics based on culture results.
  • Monitoring for toxicity: Watch for antibiotic side effects.

By focusing on infection prevention and smart antibiotic use, we can lower sepsis and death rates in ECMO patients.

ECMO Device Complications: Rare But Serious Causes of Death

ECMO is a lifesaving technology, but it can also have serious complications. These complications, though rare, are a big worry for patients on ECMO therapy.

Mechanical Failures

Mechanical failures are a big problem with ECMO devices. These failures can happen for many reasons, like equipment malfunction or manufacturing defects. A study mentioned in recent research found that these failures can cause a lot of harm and even death in ECMO patients.

To lower these risks, it’s important to regularly check and maintain ECMO equipment. Also, new technology has made ECMO devices more reliable, cutting down on mechanical failures.

Circuit-Related Complications

Circuit-related complications are another serious issue. These can include thrombosis within the circuit or infections from the ECMO circuit. Managing these complications needs a team effort, with careful monitoring and quick action.

To lessen these complications, using anticoagulation therapy to stop thrombosis and strict infection control measures are key. These steps help healthcare teams reduce the risk of circuit-related problems.

Air Embolism and Thrombotic Events

Air embolism and thrombotic events are very dangerous for ECMO patients. Air embolism can happen when the ECMO circuit is connected or disconnected. Thrombotic events can occur because the ECMO circuit can activate blood clotting.

To prevent these issues, it’s vital to be very careful during ECMO setup and maintenance. Also, using anticoagulation protocols that fit each patient’s risk is important. By knowing the risks and taking the right steps, healthcare teams can lower the chance of these serious problems.

COVID-19 and ECMO: Specific Mortality Patterns

ECMO use in COVID-19 patients shows unique mortality patterns. These patterns are key for doctors to grasp. As the pandemic changes, knowing how to better care for these patients is vital.

Findings from Major Observational Studies

Studies have given us important insights into COVID-19 patients on ECMO. A Journal of the American Medical Association (JAMA) study found a higher death rate among these patients compared to others on ECMO.

Major studies have found:

  • Mortality rates between 40% and 60% for COVID-19 patients on ECMO.
  • Longer ECMO use is linked to higher death and illness rates.
  • Conditions like high blood pressure and diabetes worsen outcomes.

Study

Patient Population

Mortality Rate

JAMA Study

COVID-19 patients on ECMO

50%

ESICM Study

COVID-19 patients on ECMO

45%

ELSO Registry

COVID-19 patients on ECMO

42%

Unique Challenges in COVID-19 ECMO Support

COVID-19 patients on ECMO face unique challenges. These include:

  1. Inflammatory Response: COVID-19’s severe inflammation makes ECMO harder to manage.
  2. Coagulopathy: These patients are at higher risk for blood clots, needing careful anticoagulation.
  3. Respiratory Complexity: Managing lung injury from COVID-19 with ECMO is complex.

Evolving Protocols for COVID-19 ECMO Management

As we learn more about COVID-19 ECMO, our protocols are improving. Key updates include:

  • Better anticoagulation strategies to reduce bleeding and clotting risks.
  • Improved ventilator techniques to lessen lung damage.
  • More use of prone positioning to better oxygen levels.

Understanding the mortality patterns and challenges of COVID-19 ECMO helps doctors improve care. This leads to better outcomes for patients.

Medical Management Strategies to Reduce ECMO Mortality

To lower ECMO death rates, doctors must use detailed medical plans. These plans cover many areas of patient care.

Optimal Anticoagulation Protocols

Keeping the ECMO system working is key. Optimal anticoagulation protocols help prevent blockages. They also lower the chance of bleeding.

We watch coagulation levels closely. This helps us adjust treatments just right. We check things like activated clotting time and anti-Xa levels.

Ventilator Management During ECMO

Managing the ventilator is very important. We aim to minimize lung injury and ensure gas exchange. We use gentle ventilation to protect the lungs.

We adjust the ventilator settings often. This keeps the patient’s oxygen and pressure levels right. It helps avoid lung damage.

Nutritional Support and Metabolic Management

Good nutritional support is vital for ECMO patients. It helps them recover. We give each patient the right amount of food, through tubes or IVs.

We also keep an eye on electrolytes and blood sugar. This helps prevent problems and supports healing.

Early Mobilization and Rehabilitation

Early mobilization and rehabilitation are key. They help patients recover faster. We start moving patients early to prevent muscle loss.

We tailor rehabilitation to each patient. It includes physical and occupational therapy. Our goal is to improve their function and quality of life.

Conclusion: Advancing ECMO Care to Improve Survival Outcomes

Improving ECMO care is key to saving more lives. The ecmo mortality rate is a big worry. This is because of multi-organ failure and breathing problems.

To make ECMO care better, we need to work on a few things. This includes finding the best way to prevent blood clots, managing breathing machines, and feeding patients well. These steps could help lower the death rate and increase survival chances.

We must keep researching and improving how we manage ECMO. This will help us tackle the tough issues with this therapy. By doing this, we can give better care to patients on ECMO. This will lead to better survival rates and improve ECMO care overall.

FAQ

What is the mortality rate for patients on ECMO?

The death rate for ECMO patients varies. It depends on the patient’s condition and the type of ECMO. Studies show that between 40% to 60% of adult patients may not survive.

Can a person die while on ECMO?

Yes, people can die on ECMO. This can happen due to organ failure, heart problems, breathing issues, or sepsis.

What is the difference in mortality rates between VA-ECMO and VV-ECMO?

VA-ECMO and VV-ECMO have different death rates. VA-ECMO is for heart support and has a higher death rate. VV-ECMO is for lungs and has a lower rate.

What are the common causes of death in ECMO patients?

Common reasons for death on ECMO include organ failure, heart issues, breathing problems, sepsis, and device issues.

How does sepsis affect ECMO mortality?

Sepsis is a big risk for ECMO patients. It can cause organ failure and make things worse. Fighting sepsis with antibiotics is key to saving lives.

What are the risks associated with ECMO therapy?

ECMO therapy comes with risks like bleeding, clotting, infections, and device problems. Close monitoring and management are needed to reduce these risks.

How can ECMO mortality be reduced?

To lower ECMO death rates, use the right anticoagulation, manage ventilation, support nutrition, and start early rehab. Choosing the right patients and managing their conditions also helps.

What is the role of comorbidities in ECMO mortality?

Conditions like diabetes, high blood pressure, and kidney problems raise the risk of death on ECMO. Managing these conditions is vital for better survival chances.

How does COVID-19 affect ECMO mortality?

COVID-19 patients on ECMO face unique challenges. They often have severe lung issues and are at higher risk for blood clots. The death rates for these patients vary, showing the need for ongoing research and better care.

What are the rare but serious complications associated with ECMO devices?

ECMO devices can lead to rare but serious issues like mechanical failures, circuit problems, and blood clots. These can be deadly and need quick action.

References

Supady, A., Dudek, L., Staudacher, D. L., Wengenmayer, T., & Rilinger, J. (2025). Mode of death after venovenous extracorporeal membrane oxygenation – A retrospective single‐center analysis. Respiratory Medicine, 246, 108250. https://doi.org/10.1016/j.rmed.2025.108250

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

LIV Hospital Expert Healthcare
Patient Reviews
Reviews from 9,651
4,9

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Our Doctors

Prof. MD. İbrahim Can Kürkçüoğlu

Prof. MD. İbrahim Can Kürkçüoğlu

Spec. MD. İrana Gorchiyeva

Spec. MD. İrana Gorchiyeva

Spec. MD. Berna Botan Yıldırım

Spec. MD. Berna Botan Yıldırım

Prof. MD. Serdar Kahraman

Prof. MD. Serdar Kahraman

Spec. MD. Zeliha Tekcan

Spec. MD. Zeliha Tekcan

Prof. MD. Peyami Cinaz

Prof. MD. Peyami Cinaz

Prof. MD. Ömer Faruk Yılmaz

Prof. MD. Ömer Faruk Yılmaz

Dt. Elif Narin Topgül

Dt. Elif Narin Topgül

Spec. MD. Yıldız Gonca Doğru

Spec. MD. Yıldız Gonca Doğru

Assoc. Prof. MD. Şefika Nur Aksoy

Assoc. Prof. MD. Şefika Nur Aksoy

Spec. MD. Zühal Çakmak Pekşen

Spec. MD. Zühal Çakmak Pekşen

Assoc. Prof. MD. Selman Emiroğlu

Assoc. Prof. MD. Selman Emiroğlu

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 71 24